The DOI matches its Crossref record; 264 of the 264 references it cites were found in a registry or an index.
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Open accessAbstract
SUMMARY: Therapy of invasive infections due to multidrug-resistant Enterobacteriaceae (MDR-E) is challenging, and some of the few active drugs are not available in many countries. For extended-spectrum β-lactamase and AmpC producers, carbapenems are the drugs of choice, but alternatives are needed because the rate of carbapenem resistance is rising. Potential active drugs include classic and newer β-lactam–β-lactamase inhibitor combinations, cephamycins, temocillin, aminoglycosides, tigecycline, fosfomycin, and, rarely, fluoroquinolones or trimethoprim-sulfamethoxazole. These drugs might be considered in some specific situations. AmpC producers are resistant to cephamycins, but cefepime is an option. In the case of carbapenemase-producing Enterobacteriaceae (CPE), only some “second-line” drugs, such as polymyxins, tigecycline, aminoglycosides, and fosfomycin, may be active; double carbapenems can also be considered in specific situations. Combination therapy is associated with better outcomes for high-risk patients, such as those in septic shock or with pneumonia. Ceftazidime-avibactam was recently approved and is active against KPC and OXA-48 producers; the available experience is scarce but promising, although development of resistance is a concern. New drugs active against some CPE isolates are in different stages of development, including meropenem-vaborbactam, imipenem-relebactam, plazomicin, cefiderocol, eravacycline, and aztreonam-avibactam. Overall, therapy of MDR-E infection must be individualized according to the susceptibility profile, type, and severity of infection and the features of the patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449 · cited 2×
“The inability of ESBLs to efficiently hydrolyze cephamycins, which include cefoxitin, cefotetan, cefmetazole, moxalactam, and flomoxef, means that cephamycins are active against ESBL producers in the absence of other resistance mechanisms (2).”
BackgroundLiu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
Munoz-Price, L. S., Poirel, L., Bonomo, R. A., Schwaber, M. J., Daikos, G. L., Cormican, M., Cornaglia, G., Garau, J., Gniadkowski, M., Hayden, M. K., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70190-7 · Cited by 1,627
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T., & Daikos, G. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05035-11 · Cited by 1,191
Tumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,016
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Pitout, J. D. D., Nordmann, P., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01019-15 · Cited by 852
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Lee, C.-R., Lee, J. H., Park, K. S., Kim, Y. B., Jeong, B. C., & Lee, S. H. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00895 · Cited by 739
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
van Duin, D., Lok, J. J., Earley, M., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Doi, Y., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix783 · Cited by 655
Daikos, G. L., Tsaousi, S., Tzouvelekis, L. S., Anyfantis, I., Psichogiou, M., Argyropoulou, A., Stefanou, I., Sypsa, V., Miriagou, V., Nepka, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02166-13 · Cited by 597
Landman, D., Georgescu, C., Martin, D. A., & Quale, J. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-08 · Cited by 565
Qureshi, Z. A., Paterson, D. L., Potoski, B. A., Kilayko, M. C., Sandovsky, G., Sordillo, E., Polsky, B., Adams-Haduch, J. M., & Doi, Y. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06268-11 · Cited by 559
van Duin, D., & Bonomo, R. A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw243 · Cited by 549
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., & Yu, V. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2206-2212.2001 · Cited by 546
Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China
Zhang, R., Liu, L., Zhou, H., Chan, E. W., Li, J., Fang, Y., Li, Y., Liao, K., & Chen, S. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.032 · Cited by 542
Gutiérrez-Gutiérrez, B., Salamanca, E., de Cueto, M., Hsueh, P.-R., Viale, P., Paño-Pardo, J. R., Venditti, M., Tumbarello, M., Daikos, G., Cantón, R., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30228-1 · Cited by 512
Self-citationTumbarello, M., Trecarichi, E. M., De Rosa, F. G., Giannella, M., Giacobbe, D. R., Bassetti, M., Losito, A. R., Bartoletti, M., Del Bono, V., Corcione, S., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv086 · Cited by 511
Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Potoski, B. A., Marini, R. V., Doi, Y., Kreiswirth, B. N., & Clancy, C. J. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00883-17 · Cited by 495
Plachouras, D., Karvanen, M., Friberg, L. E., Papadomichelakis, E., Antoniadou, A., Tsangaris, I., Karaiskos, I., Poulakou, G., Kontopidou, F., Armaganidis, A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01361-08 · Cited by 494
Falagas, M. E., Kastoris, A. C., Kapaskelis, A. M., & Karageorgopoulos, D. E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70325-1 · Cited by 487
Shields, R. K., Chen, L., Cheng, S., Chavda, K. D., Press, E. G., Snyder, A., Pandey, R., Doi, Y., Kreiswirth, B. N., Nguyen, M. H., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02097-16 · Cited by 484
Hirsch, E. B., & Tam, V. H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq108 · Cited by 477
Tumbarello, M., Sanguinetti, M., Montuori, E., Trecarichi, E. M., Posteraro, B., Fiori, B., Citton, R., D'Inzeo, T., Fadda, G., Cauda, R., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01509-06 · Cited by 461
Zarkotou, O., Pournaras, S., Tselioti, P., Dragoumanos, V., Pitiriga, V., Ranellou, K., Prekates, A., Themeli-Digalaki, K., & Tsakris, A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03514.x · Cited by 438
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
Morrill, H. J., Pogue, J. M., Kaye, K. S., & LaPlante, K. L. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv050 · Cited by 435
Sandri, A. M., Landersdorfer, C. B., Jacob, J., Boniatti, M. M., Dalarosa, M. G., Falci, D. R., Behle, T. F., Bordinhão, R. C., Wang, J., Forrest, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit334 · Cited by 430
Shields, R. K., Potoski, B. A., Haidar, G., Hao, B., Doi, Y., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J., & Nguyen, M. H. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw636 · Cited by 430
Hecker, S. J., Reddy, K. R., Totrov, M., Hirst, G. C., Lomovskaya, O., Griffith, D. C., King, P., Tsivkovski, R., Sun, D., Sabet, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00127 · Cited by 422
Carmeli, Y., Armstrong, J., Laud, P. J., Newell, P., Stone, G., Wardman, A., & Gasink, L. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30004-4 · Cited by 417
Durante-Mangoni, E., Signoriello, G., Andini, R., Mattei, A., De Cristoforo, M., Murino, P., Bassetti, M., Malacarne, P., Petrosillo, N., Galdieri, N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit253 · Cited by 405
Mazuski, J. E., Gasink, L. B., Armstrong, J., Broadhurst, H., Stone, G. G., Rank, D., Llorens, L., Newell, P., & Pachl, J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw133 · Cited by 393
Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli
Rodríguez-Baño, J., Alcalá, J. C., Cisneros, J. M., Grill, F., Oliver, A., Horcajada, J. P., Tórtola, T., Mirelis, B., Navarro, G., Cuenca, M., et al. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.17.1897 · Cited by 379
Self-citationPaul, M., Lador, A., Grozinsky-Glasberg, S., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub3 · Cited by 377
Rodriguez-Bano, J., Navarro, M. D., Retamar, P., Picon, E., Pascual, A., & the Extended-Spectrum Beta-Lactamases-Red Espanola de Investigacion en Patologia Infecciosa/Grupo de Estudio de Infeccion Hospitalaria Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir790 · Cited by 363
Self-citationWagenlehner, F. M., Sobel, J. D., Newell, P., Armstrong, J., Huang, X., Stone, G. G., Yates, K., & Gasink, L. B. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw378 · Cited by 362
Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae
Anderson, K. F., Lonsway, D. R., Rasheed, J. K., Biddle, J., Jensen, B., McDougal, L. K., Carey, R. B., Thompson, A., Stocker, S., Limbago, B., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00015-07 · Cited by 355
Vardakas, K. Z., Tansarli, G. S., Rafailidis, P. I., & Falagas, M. E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks301 · Cited by 354
Falagas, M. E., Lourida, P., Poulikakos, P., Rafailidis, P. I., & Tansarli, G. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01222-13 · Cited by 351
Capone, A., Giannella, M., Fortini, D., Giordano, A., Meledandri, M., Ballardini, M., Venditti, M., Bordi, E., Capozzi, D., Balice, M. P., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12070 · Cited by 346
Livermore, D. M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., & Woodford, N. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.012 · Cited by 341
Doi, Y., Wachino, J.-I., & Arakawa, Y. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.011 · Cited by 341
Tamma, P. D., Han, J. H., Rock, C., Harris, A. D., Lautenbach, E., Hsu, A. J., Avdic, E., & Cosgrove, S. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ003 · Cited by 314
Worldwide Diversity of Klebsiella pneumoniae That Produce β-Lactamase blaKPC-2Gene1
Cuzon, G., Naas, T., Truong, H., Villegas, M.-V., Wisell, K. T., Carmeli, Y., Gales, A. C., Navon-Venezia, S., Quinn, J. P., & Nordmann, P. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1609.091389 · Cited by 307
Marshall, S., Hujer, A. M., Rojas, L. J., Papp-Wallace, K. M., Humphries, R. M., Spellberg, B., Hujer, K. M., Marshall, E. K., Rudin, S. D., Perez, F., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02243-16 · Cited by 293
Solomkin, J., Evans, D., Slepavicius, A., Lee, P., Marsh, A., Tsai, L., Sutcliffe, J. A., & Horn, P. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2016.4237 · Cited by 276
Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
Livermore, D. M., Warner, M., & Mushtaq, S. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt178 · Cited by 268
Efficacy and safety of tigecycline: a systematic review and meta-analysis
Yahav, D., Lador, A., Paul, M., & Leibovici, L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr242 · Cited by 266
Livermore, D. M., Mushtaq, S., Warner, M., Zhang, J., Maharjan, S., Doumith, M., & Woodford, N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00756-10 · Cited by 261
Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
Tasina, E., Haidich, A.-B., Kokkali, S., & Arvanitidou, M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70177-3 · Cited by 260
Colistin: new lessons on an old antibiotic
Yahav, D., Farbman, L., Leibovici, L., & Paul, M. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03734.x · Cited by 259
Satlin, M. J., Chen, L., Patel, G., Gomez-Simmonds, A., Weston, G., Kim, A. C., Seo, S. K., Rosenthal, M. E., Sperber, S. J., Jenkins, S. G., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02349-16 · Cited by 252
Kohira, N., West, J., Ito, A., Ito-Horiyama, T., Nakamura, R., Sato, T., Rittenhouse, S., Tsuji, M., & Yamano, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01695-15 · Cited by 247
De Pascale, G., Montini, L., Pennisi, M. A., Bernini, V., Maviglia, R., Bello, G., Spanu, T., Tumbarello, M., & Antonelli, M. (2014) · Critical Care · doi:10.1186/cc13858 · Cited by 245
Thomson, K. S., & Moland, E. S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3548-3554.2001 · Cited by 245
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Zavascki, A. P., & Nation, R. L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02319-16 · Cited by 239
Daikos, G. L., & Markogiannakis, A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03553.x · Cited by 238
Sutcliffe, J. A., O'Brien, W., Fyfe, C., & Grossman, T. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-13 · Cited by 235
Mohamed, A. F., Karaiskos, I., Plachouras, D., Karvanen, M., Pontikis, K., Jansson, B., Papadomichelakis, E., Antoniadou, A., Giamarellou, H., Armaganidis, A., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06426-11 · Cited by 234
Systematic Review and Meta-Analysis of In Vitro Synergy of Polymyxins and Carbapenems
Zusman, O., Avni, T., Leibovici, L., Adler, A., Friberg, L., Stergiopoulou, T., Carmeli, Y., & Paul, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01230-13 · Cited by 233
Plasmid-mediated quinolone resistance: Two decades on
Rodríguez-Martínez, J. M., Machuca, J., Cano, M. E., Calvo, J., Martínez-Martínez, L., & Pascual, A. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.09.001 · Cited by 232
Self-citationRamirez, J., Dartois, N., Gandjini, H., Yan, J. L., Korth-Bradley, J., & McGovern, P. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01232-12 · Cited by 231
Karageorgopoulos, D. E., Wang, R., Yu, X.-H., & Falagas, M. E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr466 · Cited by 228
Rojas, L. J., Salim, M., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Marshall, S., Rudin, S. D., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw805 · Cited by 224
Pontikis, K., Karaiskos, I., Bastani, S., Dimopoulos, G., Kalogirou, M., Katsiari, M., Oikonomou, A., Poulakou, G., Roilides, E., & Giamarellou, H. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.09.010 · Cited by 220
Mediavilla, J. R., Patrawalla, A., Chen, L., Chavda, K. D., Mathema, B., Vinnard, C., Dever, L. L., & Kreiswirth, B. N. (2016) · mBio · doi:10.1128/mbio.01191-16 · Cited by 218
Hackel, M. A., Tsuji, M., Yamano, Y., Echols, R., Karlowsky, J. A., & Sahm, D. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00093-17 · Cited by 202
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
Zhanel, G. G., Lawson, C. D., Zelenitsky, S., Findlay, B., Schweizer, F., Adam, H., Walkty, A., Rubinstein, E., Gin, A. S., Hoban, D. J., et al. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.25 · Cited by 201
Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae
Bulik, C. C., & Nicolau, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01420-10 · Cited by 200
Use of Monte Carlo Simulation to Design an Optimized Pharmacodynamic Dosing Strategy for Meropenem
Kuti, J. L., Dandekar, P. K., Nightingale, C. H., & Nicolau, D. P. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003257225 · Cited by 199
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock
Taccone, F. S., Laterre, P.-F., Spapen, H., Dugernier, T., Delattre, I., Layeux, B., De Backer, D., Wittebole, X., Wallemacq, P., Vincent, J.-L., et al. (2010) · Critical Care · doi:10.1186/cc8945 · Cited by 199
Cai, Y., Wang, R., Liang, B., Bai, N., & Liu, Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01402-10 · Cited by 189
Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
Ito-Horiyama, T., Ishii, Y., Ito, A., Sato, T., Nakamura, R., Fukuhara, N., Tsuji, M., Yamano, Y., Yamaguchi, K., & Tateda, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03098-15 · Cited by 187
Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City
Lapuebla, A., Abdallah, M., Olafisoye, O., Cortes, C., Urban, C., Landman, D., & Quale, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00830-15 · Cited by 181
Stachyra, T., Levasseur, P., Pechereau, M.-C., Girard, A.-M., Claudon, M., Miossec, C., & Black, M. T. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp197 · Cited by 180
Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
DeRyke, C. A., Crawford, A. J., Uddin, N., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01707-09 · Cited by 178
Mena, A., Plasencia, V., García, L. M., Hidalgo, O., Ayestarán, I., Albertí, S., Borrell, N., Pérez, J. L., & Oliver, A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00418-06 · Cited by 177
Samonis, G., Maraki, S., Karageorgopoulos, D. E., Vouloumanou, E. K., & Falagas, M. E. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1360-5 · Cited by 177
Lee, N.-Y., Lee, C.-C., Huang, W.-H., Tsui, K.-C., Hsueh, P.-R., & Ko, W.-C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis916 · Cited by 175
Trecarichi, E. M., Pagano, L., Martino, B., Candoni, A., Blasi, R. D., Nadali, G., Fianchi, L., Delia, M., Sica, S., Perriello, V. M., et al. (2016) · American Journal of Hematology · doi:10.1002/ajh.24489 · Cited by 175
Pérez, F., Chakhtoura, N. G. E., Papp‐Wallace, K. M., Wilson, B. M., & Bonomo, R. A. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1145658 · Cited by 174
The Use of Cefepime for Treating AmpC β-Lactamase–Producing Enterobacteriaceae
Tamma, P. D., Girdwood, S. C. T., Gopaul, R., Tekle, T., Roberts, A. A., Harris, A. D., Cosgrove, S. E., & Carroll, K. C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit395 · Cited by 172
Castanheira, M., Huband, M. D., Mendes, R. E., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00567-17 · Cited by 170
Aktaş, Z., Kayacan, C., & Oncul, O. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.012 · Cited by 169
Zusman, O., Altunin, S., Koppel, F., Dishon Benattar, Y., Gedik, H., & Paul, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw377 · Cited by 169
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
Falagas, M. E., Karageorgopoulos, D. E., & Nordmann, P. (2011) · Future Microbiology · doi:10.2217/fmb.11.49 · Cited by 167
Pilato, V. D., Arena, F., Tascini, C., Cannatelli, A., Angelis, L. H. D., Fortunato, S., Giani, T., Menichetti, F., & Rossolini, G. M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01075-16 · Cited by 167
Gutiérrez‐Gutiérrez, B., Pérez-Galera, S. I., Salamanca, E., de Cueto, M., Calbo, E., Almirante, B., Viale, P., Oliver, A., Pintado, V., Gasch, O., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00365-16 · Cited by 167
Self-citationJean, S., Coombs, G. W., Ling, T. K. �., Veeraraghavan, B., Rodrigues, C. S., Mikamo, H., Kim, M. J., Rajasekaram, G., Mendoza, M. T., Tan, T. Y., et al. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.01.008 · Cited by 164
Clinical significance of extended-spectrum β-lactamases
Rodríguez-Baño, J., & Pascual, A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.671 · Cited by 163
Self-citationA review of tigecycline — the first glycylcycline
Peterson, L. R. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70005-6 · Cited by 161
Falcone, M., Russo, A., Iacovelli, A., Restuccia, G., Ceccarelli, G., Giordano, A., Farcomeni, A., Morelli, A., & Venditti, M. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.016 · Cited by 160
Vidal, L., Gafter-Gvili, A., Borok, S., Fraser, A., Leibovici, L., & Paul, M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm193 · Cited by 158
Castón, J. J., Lacort-Peralta, I., Martín‐Dávila, P., Loeches, B., Tabares, S., Temkin, L., Torre‐Cisneros, J., & Paño‐Pardo, J. R. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.03.021 · Cited by 154
Livermore, D. M., Mushtaq, S., Warner, M., & Woodford, N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00436-16 · Cited by 152
Dobias, J., Tendon, V. D., Poirel, L., & Nordmann, P. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3063-z · Cited by 151
Tängdén, T., Hickman, R. A., Forsberg, P., Lagerbäck, P., Giske, C. G., & Cars, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00741-13 · Cited by 148
Elliott, E., Brink, A. J., van Greune, J., Els, Z., Woodford, N., Turton, J. F., Warner, M., & Livermore, D. M. (2006) · Clinical Infectious Diseases · doi:10.1086/503264 · Cited by 147
Hirsch, E. B., Ledesma, K. R., Chang, K., Schwartz, M. S., Motyl, M. R., & Tam, V. H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05927-11 · Cited by 145
Pitout, J. D. D., Gregson, D. B., Campbell, L., & Laupland, K. B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00247-09 · Cited by 145
Pangon, B., Bizet, C., Buré, A., Pichon, F., Philippon, A., Regnier, B., & Gutmann, L. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.5.1005 · Cited by 142
Haidar, G., Clancy, C. J., Chen, L., Samanta, P., Shields, R. K., Kreiswirth, B. N., & Nguyen, M. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00642-17 · Cited by 142
Biedenbach, D. J., Kazmierczak, K. M., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00206-15 · Cited by 141
Ng, T. M., Khong, W. X. L., Harris, P. N. A., De, P. P., Chow, A. L., Tambyah, P. A., & Lye, D. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153696 · Cited by 140
Lob, S. H., Hackel, M., Kazmierczak, K. M., Young, K., Motyl, M. R., Karlowsky, J. A., & Sahm, D. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02209-16 · Cited by 140
Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature
Vardakas, K. Z., Legakis, N. J., Triarides, N. A., & Falagas, M. E. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.02.001 · Cited by 139
Castanheira, M., Rhomberg, P. R., Flamm, R. K., & Jones, R. N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00711-16 · Cited by 135
Endimiani, A., Choudhary, Y., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00641-09 · Cited by 133
Satlin, M. J., Kubin, C. J., Blumenthal, J. S., Cohen, A. B., Furuya, E. Y., Wilson, S. J., Jenkins, S. G., & Calfee, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00387-11 · Cited by 132
Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
Francisco, C. N.-S., Mora-Rillo, M., Romero‐Gómez, M. P., Moreno-Ramos, F., Rico-Nieto, A., Carrascoso, G. R., Gómez-Gil, R., Arribas, J. R., Mingorance, J., & Paño‐Pardo, J. R. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12091 · Cited by 130
Li, H., Estabrook, M. A., Jacoby, G. A., Nichols, W. W., TESTA, R. T., & Bush, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04191-14 · Cited by 130
Shields, R. K., Nguyen, M. H., Press, E. G., Chen, L., Kreiswirth, B. N., & Clancy, C. J. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx101 · Cited by 130
Matsumura, Y., Yamamoto, M., Nagao, M., Komori, T., Fujita, N., Hayashi, A., Shimizu, T., Watanabe, H., Doi, S., Tanaka, M., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00701-15 · Cited by 129
Popejoy, M. W., Paterson, D. L., Cloutier, D. J., Huntington, J. A., Miller, B. W., Bliss, C. A., Steenbergen, J. N., Hershberger, E., Umeh, O., & Kaye, K. S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw374 · Cited by 129
Tascini, C., Tagliaferri, E., Giani, T., Leonildi, A., Flammini, S., Casini, B., Lewis, R. E., Ferranti, S., Rossolini, G. M., & Menichetti, F. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00179-13 · Cited by 127
Burkhardt, O., Kumar, V., Katterwe, D., Majcher-Peszynska, J., Drewelow, B., Derendorf, H., & Welte, T. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl485 · Cited by 122
Falagas, M. E., Skalidis, T., Vardakas, K. Z., Legakis, N. J., & on behalf of the Hellenic Cefiderocol Study Group (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx049 · Cited by 122
Livermore, D. M., Mushtaq, S., Warner, M., Miossec, C., & Woodford, N. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn320 · Cited by 120
Coexistence of mcr-1 and bla NDM-1 in Escherichia coli from Venezuela
Delgado‐Blas, J. F., Ovejero, C. M., Abadía-Patiño, L., & González‐Zorn, B. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01319-16 · Cited by 118
Emergence of imipenem resistance in clinical Escherichia coli during therapy
Oteo, J., Delgado‐Iribarren, A., Vega, D., Bautista, V., Rodríguez, M. C., Velasco, M., Saavedra, J. M., Pérez-Vázquez, M. D., García-Cobos, S., Martínez-Martínez, L., et al. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.06.012 · Cited by 117
Balakrishnan, I., Awad-El-Kariem, F. M., Aali, A., Kumari, P., Mulla, R., Tan, B., Brudney, D., Ladenheim, D., Ghazy, A., Khan, I., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr317 · Cited by 116
Chopra, T., Marchaim, D., Veltman, J., Johnson, P., Zhao, J. J., Tansek, R., Hatahet, D., Chaudhry, K., Pogue, J. M., Hiro, R., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05419-11 · Cited by 115
Seo, Y. B., Lee, J., Kim, Y. K., Lee, S. S., Lee, J.-A., Kim, H. Y., Uh, Y., Kim, H.-S., & Song, W. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2502-x · Cited by 115
Stein, C., Makarewicz, O., Bohnert, J. A., Pfeifer, Y., Kesselmeier, M., Hagel, S., & Pletz, M. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126479 · Cited by 114
Lee, C.-H., Su, L.-H., Tang, Y., & Liu, J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl381 · Cited by 114
Karaiskos, I., Friberg, L. E., Pontikis, K., Ioannidis, K., Tsagkari, V., Galani, L., Kostakou, E., Baziaka, F., Paskalis, C., Koutsoukou, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00554-15 · Cited by 113
Kazmierczak, K. M., Biedenbach, D. J., Hackel, M., Rabine, S., DeJonge, B. L. M., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00107-16 · Cited by 113
Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
Docobo-Pérez, F., Drusano, G. L., Johnson, A., Goodwin, J., Whalley, S., Ramos-Martin, V., Ballestero-Téllez, M., Rodríguez-Martínez, J. M., Conejo, M. C., Guilder, M. V., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00752-15 · Cited by 112
Self-citationBalkan, İ. İ., Aygün, G., Aydın, S., Mutcalı, S. I., Kara, Z., Kuşkucu, M. A., Midilli, K., Şemen, V., Aras, Ş., Yemişen, M., et al. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.05.012 · Cited by 112
Endimiani, A., Luzzaro, F., Perilli, M., Lombardi, G., Coli, A., Tamborini, A., Amicosante, G., & Toniolo, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380645 · Cited by 112
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections
Ni, W., Han, Y., Liu, J., Wei, C., Zhao, J., Cui, J., Wang, R., & Liu, Y.-N. (2016) · Medicine · doi:10.1097/md.0000000000003126 · Cited by 112
Ong, D. S. Y., Frencken, J. F., Klein Klouwenberg, P. M. C., Juffermans, N., van der Poll, T., Bonten, M. J. M., & Cremer, O. L. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix186 · Cited by 109
Crandon, J. L., & Nicolau, D. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01989-12 · Cited by 108
Dalfino, L., Puntillo, F., Ondok, M. J. M., Mosca, A., Monno, R., Coppolecchia, S., Spada, M. L., Bruno, F., & Brienza, N. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ717 · Cited by 108
Vicari, G., Bauer, S. R., Neuner, E. A., & Lam, S. W. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis909 · Cited by 107
Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens
Poulakou, G., Kontopidou, F. V., Paramythiotou, E., Kompoti, M., Katsiari, M., Mainas, E., Nicolaou, C., Yphantis, D., Antoniadou, A., Trikka‐Graphakos, E., et al. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.02.009 · Cited by 106
Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint
Burkhardt, O., Rauch, K., Kaever, V., Hadem, J., Kielstein, J. T., & Welte, T. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.01.015 · Cited by 106
González-Padilla, M., Torre‐Cisneros, J., Rivera-Espinar, F., Pontes-Moreno, A., López‐Cerero, L., Pascual, Á., Natera, C., Rodriguez, M., Salcedo-Leal, I., Rodríguez-López, F., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku432 · Cited by 104
Self-citationPASCALE, G. D., Martucci, G., Montini, L. M., Panarello, G., Cutuli, S. L., Carlo, D. D., Gravio, V. D., Stefano, R. D., Capitanio, G., Vallecoccia, M. S., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1769-z · Cited by 103
Paño‐Pardo, J. R., Carrascoso, G. R., Francisco, C. N.-S., Gómez-Gil, R., Mora-Rillo, M., Romero‐Gómez, M. P., Fernández-Romero, N., García‐Rodríguez, J., Pérez-Blanco, V., Moreno-Ramos, F., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks364 · Cited by 102
Vasilev, K. A., Reshedko, G., Orăsan, R., Sánchez, M., Teras, J., Babinchak, T., Dukart, G., Cooper, A., Dartois, N., Gandjini, H., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn249 · Cited by 102
Matsumoto, S., Singley, C. M., Hoover, J. L., Nakamura, R., ECHOLS, R. M., Rittenhouse, S. F., Tsuji, M., & Yamano, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00700-17 · Cited by 101
Cheng, L., Nelson, B. C., Mehta, M., Seval, N., Park, S. E., Giddins, M. J., Shi, Q., Whittier, S., Gomez‐Simmonds, A., & Uhlemann, A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00276-17 · Cited by 98
Falagas, M. E., Vardakas, K. Z., Tsiveriotis, K., Triarides, N. A., & Tansarli, G. S. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.006 · Cited by 97
Gomez‐Simmonds, A., Nelson, B. C., Eiras, D. P., Loo, A. S., Jenkins, S. G., Whittier, S., Calfee, D. P., Satlin, M. J., Kubin, C. J., & Furuya, E. Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03007-15 · Cited by 97
Ambrose, P. G., Bhavnani, S. M., & Jones, R. N. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1643-1646.2003 · Cited by 96
Laterre, P., Wittebole, X., de Velde, S. V., Muller, A. E., Mouton, J. W., Carryn, S., Tulkens, P. M., & Dugernier, T. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku465 · Cited by 93
Optimization of Aminoglycoside Therapy
Drusano, G. L., & Louie, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01314-10 · Cited by 92
Harris, P. N. A., Wei, J. Y., Shen, A., Abdile, A. A., Paynter, S., Huxley, R., Pandeya, N., Doi, Y., Huh, K., O’Neal, C. S., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv346 · Cited by 92
Treatment options for multidrug-resistant bacteria
Giamarellou, H. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.4.601 · Cited by 91
Katsube, T., Wajima, T., Ishibashi, T., Ferreira, J. C. A., & ECHOLS, R. M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01381-16 · Cited by 91
Dautzenberg, M. J. D., Ossewaarde, J. M., de Kraker, M. E. A., van der Zee, A., van Burgh, S., de Greeff, S. C., Bijlmer, H. A., Grundmann, H., Stuart, J. W. C., Fluit, A. C., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.9.20723 · Cited by 89
Wang, X., Zhang, F., Zhao, C., Wang, Z., Nichols, W. W., TESTA, R. T., Li, H., Chen, H., He, W., Wang, Q., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02123-13 · Cited by 88
Rahim, N. A., Cheah, S.-E., Johnson, M. D., Yu, H. H., Sidjabat, H. E., Boyce, J. D., Butler, M. S., Cooper, M. A., Fu, J. W., Paterson, D. L., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv135 · Cited by 87
Allou, N., Cambau, E., Massias, L., Chau, F., & Fantin, B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01664-08 · Cited by 87
Retamar, P., López‐Cerero, L., Muniain, M. A., Pascual, Á., Rodríguez‐Baño, J., & the ESBL-REIPI/GEIH Group (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00135-13 · Cited by 86
Self-citationDosing of colistin—back to basic PK/PD
Bergen, P. J., Li, J., & Nation, R. L. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.07.004 · Cited by 86
Harada, Y., Morinaga, Y., Kaku, N., Nakamura, S., Uno, N., Hasegawa, H., Izumikawa, K., KOHNO, S., & Yanagihara, K. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12677 · Cited by 85
Yang, H., Zhang, C., Zhou, Q., Wang, Y., & Chen, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116769 · Cited by 85
Lee, N., Lee, C., Li, C., Li, M.-C., Chen, P., Chang, C., & Ko, W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01477-15 · Cited by 83
Harris, P. N. A., Peleg, A. Y., Iredell, J. R., Ingram, P. R., Miyakis, S., Stewardson, A. J., Rogers, B. A., McBryde, E. S., Roberts, J. A., Lipman, J., et al. (2015) · Trials · doi:10.1186/s13063-014-0541-9 · Cited by 82
Pharmacokinetics and Renal Disposition of Polymyxin B in an Animal Model
Abdelraouf, K., He, J., Ledesma, K. R., Hu, M., & Tam, V. H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01333-12 · Cited by 82
Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
Fukuchi, T., Iwata, K., Kobayashi, S., Nakamura, T., & Ohji, G. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1770-1 · Cited by 81
López‐Cerero, L., Picón, E., Morillo, C., Hernández, J. R., Docobo-Pérez, F., Pachón, J., Rodríguez‐Baño, J., & Pascual, Á. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02893.x · Cited by 80
Self-citationDoi, A., Shimada, T., Harada, S., Iwata, K., & Kamiya, T. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.09.010 · Cited by 80
Karlowsky, J. A., Hoban, D. J., Hackel, M., Lob, S. H., & Sahm, D. F. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000421 · Cited by 80
Livermore, D. M., Hope, R., Fagan, E. J., Warner, M., Woodford, N., & Potz, N. A. C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl043 · Cited by 79
Rosso-Fernández, C. M., Sojo-Dorado, J., Barriga, A., Lavín-Alconero, L., Palacios-Baena, Z. R., López-Hernández, I., Merino, V., Cameán, M., Pascual, Á., Rodríguez‐Baño, J., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007363 · Cited by 79
Self-citationGaibani, P., Lombardo, D., Lewis, R. E., Mercuri, M., Bonora, S., Landini, M. P., & Ambretti, S. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku065 · Cited by 79
Senol, S., Tasbakan, M. I., Pullukçu, H., Sipahi, O. R., Sipahi, H., Yamazhan, T., Arda, B., & Ulusoy, S. (2010) · Journal of Chemotherapy · doi:10.1179/joc.2010.22.5.355 · Cited by 78
Pharmacokinetic and pharmacodynamic evaluation of tigecycline
Giamarellou, H., & Poulakou, G. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.623126 · Cited by 78
Machuca, I., Gutiérrez‐Gutiérrez, B., Gracia-Ahufinger, I., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00406-17 · Cited by 78
Self-citationEndimiani, A., Hujer, K. M., Hujer, A. M., Pulse, M., Weiss, W. J., & Bonomo, R. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01198-10 · Cited by 77
Shen, F., Han, Q., Xie, D., Fang, M., Zeng, H., & Deng, Y. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.08.009 · Cited by 76
Nabarro, L., Shankar, C., Pragasam, A. K., Mathew, G., Jeyaseelan, V., Veeraraghavan, B., & Verghese, V. P. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001499 · Cited by 75
Giannella, M., Trecarichi, E. M., Giacobbe, D. R., Rosa, F. G. D., Bassetti, M., Bartoloni, A., Bartoletti, M., Losito, A. R., Bono, V. D., Corcione, S., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.08.019 · Cited by 75
Freire, M. P., Pierrotti, L. C., Caiaffa-Filho, H., Ibrahim, K. Y., Magri, A. S. G. K., Bonazzi, P., Hajar, L., Estevez-Diz, M. D. P., Pereira, J. C., Hoff, P. M., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2233-5 · Cited by 74
Docobo-Pérez, F., López‐Cerero, L., López-Rojas, R., Egea, P., Domínguez-Herrera, J., Rodríguez‐Baño, J., Pascual, Á., & Pachón, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02190-12 · Cited by 74
Self-citationThauvin-Eliopoulos, C., Tripodi, M., Moellering, R. C., & Eliopoulos, G. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1053 · Cited by 73
Treatment of KPC-producing Enterobacteriaceae: suboptimal efficacy of polymyxins
de Oliveira, M. S., de Assis, D. B., Freire, M. P., do Prado, G. V. B., Machado, A. S., Abdala, E., Pierrotti, L. C., Mangini, C., Campos, L. M., Caiaffa-Filho, H., et al. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.010 · Cited by 70
Pérez, F., & Bonomo, R. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir793 · Cited by 70
In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
Berçot, B., Poirel, L., Dortet, L., & Nordmann, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr296 · Cited by 70
Wang, R., Cosgrove, S. E., Tschudin‐Sutter, S., Han, J., Turnbull, A. E., Hsu, A. J., Avdic, E., Carroll, K. C., & Tamma, P. D. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw132 · Cited by 70
Rossi, I., Ferreira, M. L., Araújo, B. F., de Campos, P. A., Royer, S., Batistão, D. W. D. F., de Souza, L. P. M., de Brito, C. S., Urzêdo, J. E., Gontijo-Filho, P. P., et al. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.08.019 · Cited by 69
Goethaert, K., Looveren, M. V., Lammens, C., Jansens, H., Baraniak, A., Gniadkowski, M., Herck, K. V., Jorens, P. G., Demey, H. E., Ieven, M. M., et al. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01290.x · Cited by 66
MCR-1 and OXA-48 In Vivo Acquisition in KPC-Producing Escherichia coli after Colistin Treatment
Beyrouthy, R., Robin, F., Lesenne, A., Lacombat, I., Dortet, L., Naas, T., Pontiès, V., & Bonnet, R. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02540-16 · Cited by 66
Clinical management of infections caused by multidrug-resistant Enterobacteriaceae
Delgado-Valverde, M., Sojo-Dorado, J., Pascual, Á., & Rodríguez‐Baño, J. (2013) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936113476284 · Cited by 63
Self-citationDupont, H., Gaillot, O., Goetgheluck, A.-S., Plassart, C., Émond, J.-P., Lecuru, M., Gaillard, N., Derdouri, S., Lemaire, B., de Courtilles, M. G., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01559-15 · Cited by 63
Cprek, J. B., & Gallagher, J. C. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01569-15 · Cited by 63
Sharma, R., Patel, S., Abboud, C. S., Diep, J. K., Ly, N. S., Pogue, J. M., Kaye, K. S., Li, J., & Rao, G. G. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.10.025 · Cited by 61
Karageorgopoulos, D. E., Miriagou, V., TZOUVELEKIS, L. S., Spyridopoulou, K., & Daikos, G. L. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks270 · Cited by 60
Bazaz, R., Chapman, A. L. N., & Winstanley, T. G. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq152 · Cited by 59
Hirsch, E. B., Guo, B., Chang, K., Cao, H., Ledesma, K. R., Singh, M., & Tam, V. H. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis766 · Cited by 59
Zimhony, O., Chmelnitsky, I., Bardenstein, R., Goland, S., Hammer-Muntz, O., Navon‐Venezia, S., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00218-06 · Cited by 59
Cited by
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Miller, W. R., & Arias, C. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01054-w · Cited by 862
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
Castanheira, M., Simner, P. J., & Bradford, P. A. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab092 · Cited by 796
Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans
He, T., Wang, R., Liu, D., Walsh, T. R., Zhang, R., Lv, Y., Ke, Y., Ji, Q., Wei, R., Liu, Z., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0445-2 · Cited by 705
Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
Sheu, C.-C., Chang, Y.-T., Lin, S.-Y., Chen, Y.-H., & Hsueh, P.-R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00080 · Cited by 520
Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli
Sun, J., Chen, C., Cui, C.-Y., Zhang, Y., Liu, X., Cui, Z.-H., Ma, X.-Y., Feng, Y., Fang, L.-X., Lian, X.-L., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0496-4 · Cited by 484
Metadata
- Authors
- Rodríguez-Baño, J., Gutiérrez-Gutiérrez, B., Machuca, I., & Pascual, A.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2018-04
- Volume
- 31
- Issue
- 2
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2786886659
- Cited by
- 704
- References
- 264
- FWCI
- 28.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.